Europe G-CSF PEG-G-CSF Market to 2032
Overview
The Europe G-CSF PEG-G-CSF Market is expected to reach a 187.68 USD Million by 2032 and is projected to grow at a CAGR of 6.10% from 2025 to 2032.
Revenue, 2024 (USD Million)
123.75
Forecast, 2032 (USD Million)
187.68
CAGR, 2024 - 2032
6.10%
Report Coverage
Europe
Europe G-CSF PEG-G-CSF Market 2018-2032 USD Million
Europe G-CSF PEG-G-CSF Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 123.75 USD Million
- Projected Market Size (2032): 187.68 USD Million
- CAGR (2025-2032): 6.10%
Key Findings of Europe G-CSF PEG-G-CSF Market
- The Europe G-CSF PEG-G-CSF Market was valued at 187.68 USD Million in 2024.
- The Europe G-CSF PEG-G-CSF Market is likely to grow at a CAGR of 6.10% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Mono in Dosage Segment accounted for the largest share of the market with a revenue of 123.75 USD Million
- The fastest growing segment Growth Hormone Deficiency in Indication Segment grew Fastest with a CAGR of 10.37% during the forecast period from 2024 to 2032.
Europe G-CSF PEG-G-CSF Market Scope
Europe G-CSF PEG-G-CSF Market Segmentation & Scope
Indication
- Others
- Growth Hormone Deficiency
- Blood Disorders
- Chronic and Auto Immune Diseases
- Oncology
- Neutropenia
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Dosage
- Combination
- Mono
Route of Administration
- Intravenous
- Subcutaneous
Packaging
- Single Use Vials
- Pre filled Syringes
End User
- Others
- Ambulatory Surgical Centers
- Research & Academic Institutes
- Hospitals and Clinics
Europe G-CSF PEG-G-CSF Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 123.75 USD Million |
| Market Value in 2032 | 187.68 USD Million |
| CAGR (2025-2032) | 6.10% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Indication,Distribution Channel,Dosage,Route of Administration,Packaging,End User |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 123.75 USD Million in 2024
- Key Country: Russia, leading in terms of revenue with value of 104.92 USD Million in 2024.
Segments and Scope
-
Europe G-CSF PEG-G-CSF Market to 2032, By Indication
- Neutropenia is the largest segment in Europe G-CSF PEG-G-CSF Market to 2032 with a revenue of 40.73 USD Million in the year 2024.
- Growth Hormone Deficiency is the Fastest growing segment in Europe G-CSF PEG-G-CSF Market to 2032 with a Growth rate of 6.13 % in forecast period 2025-2032.
-
Europe G-CSF PEG-G-CSF Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Europe G-CSF PEG-G-CSF Market to 2032 with a revenue of 64.87 USD Million in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in Europe G-CSF PEG-G-CSF Market to 2032 with a Growth rate of 6.83 % in forecast period 2025-2032.
-
Europe G-CSF PEG-G-CSF Market to 2032, By Dosage
- Mono is the largest segment in Europe G-CSF PEG-G-CSF Market to 2032 with a revenue of 123.75 USD Million in the year 2024.
- Mono is the Fastest growing segment in Europe G-CSF PEG-G-CSF Market to 2032 with a Growth rate of 6.10 % in forecast period 2025-2032.
-
Europe G-CSF PEG-G-CSF Market to 2032, By Route of Administration
- Subcutaneous is the largest segment in Europe G-CSF PEG-G-CSF Market to 2032 with a revenue of 118.75 USD Million in the year 2024.
- Subcutaneous is the Fastest growing segment in Europe G-CSF PEG-G-CSF Market to 2032 with a Growth rate of 6.23 % in forecast period 2025-2032.
-
Europe G-CSF PEG-G-CSF Market to 2032, By Packaging
- Pre filled Syringes is the largest segment in Europe G-CSF PEG-G-CSF Market to 2032 with a revenue of 117.43 USD Million in the year 2024.
- Pre filled Syringes is the Fastest growing segment in Europe G-CSF PEG-G-CSF Market to 2032 with a Growth rate of 6.30 % in forecast period 2025-2032.
-
Europe G-CSF PEG-G-CSF Market to 2032, By End User
- Hospitals and Clinics is the largest segment in Europe G-CSF PEG-G-CSF Market to 2032 with a revenue of 63.12 USD Million in the year 2024.
- Hospitals and Clinics is the Fastest growing segment in Europe G-CSF PEG-G-CSF Market to 2032 with a Growth rate of 6.92 % in forecast period 2025-2032.
Europe G-CSF PEG-G-CSF Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Intas Pharmaceuticals Ltd. | |||
| Teva Pharmaceutical Industries Ltd. | |||
| Pfizer Inc. | |||
| STADA Arzneimittel AG | |||
Europe G-CSF PEG-G-CSF Market Geographical Sales Distribution, 2018-2032 USD Million
Europe G-CSF PEG-G-CSF Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Europe G-CSF PEG-G-CSF Market is segmented based on Segmentation Indication,Distribution Channel,Dosage,Route of Administration,Packaging,End User.
Europe G-CSF PEG-G-CSF Market was valued at USD 123.75(Revenue in USD Million) in 2020.
Europe G-CSF PEG-G-CSF Market is projected to grow at a CAGR of 6.10% during the forecast period of 2024 to 2032.
The Mono segment is expected to dominate the Europe G-CSF PEG-G-CSF Market, holding a largest market share of 123.75 USD Million in 2024
Europe G-CSF PEG-G-CSF Market Scope
Europe G-CSF PEG-G-CSF Market Segmentation & Scope
Indication
- Others
- Growth Hormone Deficiency
- Blood Disorders
- Chronic and Auto Immune Diseases
- Oncology
- Neutropenia
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Dosage
- Combination
- Mono
Route of Administration
- Intravenous
- Subcutaneous
Packaging
- Single Use Vials
- Pre filled Syringes
End User
- Others
- Ambulatory Surgical Centers
- Research & Academic Institutes
- Hospitals and Clinics
Frequently Asked Questions
The Europe G-CSF PEG-G-CSF Market is segmented based on Segmentation Indication,Distribution Channel,Dosage,Route of Administration,Packaging,End User.
Europe G-CSF PEG-G-CSF Market was valued at USD 123.75(Revenue in USD Million) in 2020.
Europe G-CSF PEG-G-CSF Market is projected to grow at a CAGR of 6.10% during the forecast period of 2024 to 2032.
The estimated market value of the Europe G-CSF PEG-G-CSF Market for final year is USD 187.68 (USD Million).
Europe G-CSF PEG-G-CSF Market Company Profiling
Frequently Asked Questions
The Europe G-CSF PEG-G-CSF Market is segmented based on Segmentation Indication,Distribution Channel,Dosage,Route of Administration,Packaging,End User.
Europe G-CSF PEG-G-CSF Market was valued at USD 123.75(Revenue in USD Million) in 2020.
Europe G-CSF PEG-G-CSF Market is projected to grow at a CAGR of 6.10% during the forecast period of 2024 to 2032.
The estimated market value of the Europe G-CSF PEG-G-CSF Market for final year is USD 187.68 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.